Arcoma AB

ST:ARCOMA Sweden Medical Devices
Market Cap
$10.23 Million
Skr114.75 Million SEK
Market Cap Rank
#29228 Global
#430 in Sweden
Share Price
Skr8.02
Change (1 day)
-6.53%
52-Week Range
Skr6.92 - Skr10.75
All Time High
Skr25.60
About

Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more

Arcoma AB (ARCOMA) - Total Liabilities

Latest total liabilities as of September 2025: Skr24.58 Million SEK

Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr24.58 Million SEK as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Arcoma AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company Country Total Liabilities
Sensen Networks Ltd
AU:SNS
Australia AU$6.40 Million
Retractable Technologies Inc
NYSE MKT:RVP
USA $69.65 Million
WMG Holdings Bhd
KLSE:6378
Malaysia RM170.29 Million
Ashima Limited
NSE:ASHIMASYN
India ₹2.81 Billion
Equatorial Resources Ltd
AU:EQX
Australia AU$190.21K
Knight Club Capital Asset Management PCL
BK:KCC
Thailand ฿1.26 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.33 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.25 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2024)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 Skr21.13 Million -36.56%
2023-12-31 Skr33.30 Million -38.84%
2022-12-31 Skr54.46 Million +54.57%
2021-12-31 Skr35.23 Million -22.57%
2020-12-31 Skr45.50 Million +19.28%
2019-12-31 Skr38.14 Million +2.43%
2018-12-31 Skr37.24 Million +36.52%
2017-12-31 Skr27.28 Million -19.55%
2016-12-31 Skr33.90 Million -1.26%
2015-12-31 Skr34.34 Million -8.40%
2014-12-31 Skr37.48 Million -35.77%
2013-12-31 Skr58.35 Million +31.57%
2012-12-31 Skr44.35 Million --